LGD-4033 (Ligandrol)

LGD-4033 (Ligandrol) is a synthetic selective androgen receptor modulator extensively utilized in laboratory research for studying androgen receptor binding, cellular signaling pathways, and protein synthesis mechanisms within muscle tissue models. It is commonly investigated for its role in modulating anabolic signaling, receptor selectivity, and downstream gene expression in controlled in vitro and in vivo research environments. Researchers value LGD-4033 for its stability and consistency when analyzing tissue-specific receptor interactions and cellular adaptation processes.

In experimental settings, LGD-4033 is used to explore its effects on muscle cell differentiation, growth signaling pathways, and nitrogen retention dynamics at the cellular level. Its well-characterized structure makes it suitable for repeatable protocols focused on receptor activity, metabolic response, and cellular development. This compound is also of interest in broader research involving endocrine signaling and tissue-specific modulation.

Reconstitution (For Research Reference Only):
Add 2mL of bacteriostatic water to achieve a concentration of 10mg/mL. At this concentration, each 0.1mL (10 units on a standard insulin syringe) corresponds to 1mg of compound. This information is provided strictly for laboratory research standardization and measurement purposes.

This product is supplied in lyophilized (freeze-dried) form within a sealed vial to ensure stability and precision in handling. It is intended exclusively for laboratory research, analytical, and educational purposes and is not approved for—and must not be used for—human or animal consumption.